PMI (NYSEAMERICAN:PMI) Shares Climb 2.8% – Should You Buy?

PMI (NYSEAMERICAN:PMI)’s stock price traded up 2.8% during trading on Monday. The company traded as high as $9.14 and last traded at $8.58. Approximately 41,410 shares changed hands during trading, a decline of 93% from the average session volume of 599,560 shares. The stock had previously closed at $8.35.

Trending Headlines about PMI

Here are the key news stories impacting PMI this week:

• Positive Sentiment: Permanent CEO appointment may reduce leadership uncertainty. Picard Medical Appoints Richard Fang as Permanent CEO
• Neutral Sentiment: Most of the other headlines concern economic purchasing managers’ index readings, not Picard Medical’s business, and are not direct catalysts for PMI shares.
• Negative Sentiment: The company’s latest reported results remain a significant potential overhang: it posted a quarterly loss of $3.05 per share on $2.95 million in revenue, alongside a deeply negative net margin. These results were reported in August, rather than in the recent news flow.

PMI Trading Down 7.6%

The business has a fifty day simple moving average of $7.29 and a two-hundred day simple moving average of $28.62.

PMI (NYSEAMERICAN:PMI) last posted its earnings results on Wednesday, August 19th. The company reported ($3.05) EPS for the quarter. The firm had revenue of $2.95 million for the quarter. PMI had a negative net margin of 444.83% and a negative return on equity of 825.18%. As a group, equities analysts forecast that PMI will post -8.50 EPS for the current year.

PMI Company Profile

Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.